Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jim Lackey
AddedFeb 15, 2024
UpdatedMay 31, 2026
Jim Lackey

Jim Lackey

Board Member, PatientFocus

Crunchbase

Jim Lackey's Career

PatientFocus
PatientFocus

Nashville, TN, US

Board Member· Board
Complete Holdings Group
Complete Holdings Group

Franklin, TN, US

Board Member· Board
Concert Genetics
Concert Genetics

Franklin, TN, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jim Lackey's Career

PatientFocus
PatientFocus
Seed$1M232010Nashville, TN, US
Board Member· Board

Similar to PatientFocus

PatientPayPatientPayDurham, NC, USest. 2008PatientPayDurham, NC, US · est. 2008

PatientPay, a leader in healthcare payments, offers a secure, cloud-based service for easy and efficient bill processing and collection.

Series A · $30.8M23
PatientFiPatientFiIrvine, CA, USest. 2017PatientFiIrvine, CA, US · est. 2017

PatientFi, a financial services firm, partners with healthcare providers to offer affordable patient plans.

Series B · $27.7M57
Decoda HealthDecoda HealthSan Francisco, CA, USHealthcare Admin, Patient Billingest. 2023Decoda HealthSan Francisco, CA, US · est. 2023

Decoda Health: Simplifying patient billing and healthcare admin with AI.

Pre-Seed · $500k4
Patient PremierPatient PremierBaltimore, MD, USMedical SaaSest. 2019Patient PremierBaltimore, MD, US · est. 2019

Medical SaaS provider transforming patient-reported outcomes and physiologic data into valuable insights.

Angel · $200k4
Complete Holdings Group
Complete Holdings Group
Investment FirmInvestment Firm$6.5M302000Franklin, TN, US
Board Member· Board

Leadership at Complete Holdings Group

David IskoweDavid IskoweFounder
David JonesDavid JonesCEO

Similar to Complete Holdings Group

Collective HealthCollective HealthSan Francisco, CA, USest. 2013Collective HealthSan Francisco, CA, US · est. 2013

CollectiveHealth: A cloud-based platform providing employer self-insurance and healthcare solutions in the US.

Investment Firm · $719M719
TailorWell HoldingsTailorWell HoldingsSeattle, WA, USest. 2014TailorWell HoldingsSeattle, WA, US · est. 2014

TailorWell: A comprehensive platform for managing health plans, employee data, and premium transactions.

Investment Firm · $860k30
EmployersEmployersReno, NV, USest. 1913EmployersReno, NV, US · est. 1913

Employers Holdings, Inc. offers workers' compensation insurance, focusing on small to medium hazard industries.

Investment Firm676
HealthonomyHealthonomyMenlo Park, CA, USest. 2010HealthonomyMenlo Park, CA, US · est. 2010

Healthonomy: A web-based data management tool for medical providers in the California Workers' Compensation Program.

Investment Firm · $322.5k5
Concert Genetics
Concert Genetics
Acquired$9.1M02010Franklin, TN, US
Board Member· Board

Leadership at Concert Genetics

Patrick J. BalthropPatrick J. BalthropBoard Member
Jim D. KeverJim D. KeverBoard Member
Curt ThorneCurt ThorneBoard Member
Rob MetcalfRob MetcalfCEO
Phil HertikPhil HertikBoard Member
Mark HarrisMark HarrisFounder

Similar to Concert Genetics

InvitaeInvitaeSan Francisco, CA, USGenetic Testingest. 2010InvitaeSan Francisco, CA, US · est. 2010

Invitae Corp., a global genetic information company, specializes in diagnostics, oncology, pediatrics, and hereditary screening.

Public · $2.5B1.7k
GeneDx HoldingsGeneDx HoldingsStamford, CT, USGenetic Testingest. 2017GeneDx HoldingsStamford, CT, US · est. 2017

Connecticut-based GeneDx, a software company merging diagnostics and data science for personalized health insights.

Public · $941M919
GentecGentecColorado Springs, CO, USGenetic Testingest. 2014GentecColorado Springs, CO, US · est. 2014

GENTEC: Advanced genetic testing lab enhancing health knowledge through DNA disorder identification.

Pre-Seed · $30k20
GeneticureGeneticureMinneapolis, MN, USGenetic Testingest. 2016GeneticureMinneapolis, MN, US · est. 2016

Geneticure: A personalized medicine firm offering patented tests for cost-effective, rapid chronic disease control.

Seed · $6M11

Jim Lackey's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoMason YeoMason YeoBoard Member · Kakao

People Similar to Jim Lackey

Glenn LakenGlenn LakenBoard Member · CMG Holdings GroupSteven PetrevskiSteven PetrevskiBoard Member · ConvergeJay WeintraubJay WeintraubBoard Member · Conference HoundDon GayhardtDon GayhardtBoard Member · KatapultMac LackeyMac LackeyCo-Founder · iXL